Literature DB >> 6732050

A comparison of in vivo and in vitro human airway reactivity to histamine.

C L Armour, N M Lazar, R R Schellenberg, S M Taylor, N Chan, J C Hogg, P D Paré.   

Abstract

To examine for a relationship between in vivo nonspecific bronchial reactivity to histamine and in vitro smooth muscle response to histamine, we performed inhalation dose-response curves prior to lung surgery in 12 patients and compared this with their bronchial smooth muscle response in vitro. In vivo reactivity was assessed by the provocative concentration of histamine resulting in a 20% fall in forced expiratory volume in one second (PC20), and in vitro reactivity was measured by the negative log of the molar concentration of histamine producing 50% maximal contraction (pD2) as well as maximal tension generated (Tmax). In addition, morphometric analysis was performed on the in vitro tissue to quantitate the amount of smooth muscle present. A wide range of in vivo responses was found in the 12 subjects (PC20-0.065 lead to 16). There was less in vitro variability and no correlation between PC20 and in vitro reactivity assessed by pD20 or Tmax or between PC20 and the percent of smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732050     DOI: 10.1164/arrd.1984.129.6.907

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

Review 1.  Bronchial provocation tests with pharmacological agents.

Authors:  C B Robinson; G H Parsons
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

2.  Homologous serum increases fibronectin expression and cell adhesion in airway smooth muscle cells.

Authors:  I A Shiels; S D Bowler; S M Taylor
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

3.  Effect of breathing pattern during inhalation challenge on the shape and position of the dose-response curve.

Authors:  S Guillemi; A L James; P D Pare
Journal:  Lung       Date:  1989       Impact factor: 2.584

Review 4.  Role of inflammation in the hyperreactivity of the airways in asthma.

Authors:  K F Chung
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

5.  The pathophysiology of bronchial asthma and targets for its drug treatment.

Authors:  S T Holgate
Journal:  Agents Actions       Date:  1986-06

6.  Responsiveness of human isolated bronchial segments and its relationship to epithelial loss.

Authors:  T I Omari; M P Sparrow; H W Mitchell
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

7.  Evidence for the absence of a functional role for muscarinic M2 inhibitory receptors in cat trachea in vivo: contrast with in vitro results.

Authors:  C R Killingsworth; M F Yu; N E Robinson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

8.  Comparison of human bronchiolar smooth muscle responsiveness in vitro with histological signs of inflammation.

Authors:  J C de Jongste; H Mons; R Van Strik; I L Bonta; K F Kerrebijn
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

9.  Bronchial reactivity to methacholine after combined heart-lung transplantation.

Authors:  N R Banner; R Heaton; L Hollingshead; A Guz; M H Yacoub
Journal:  Thorax       Date:  1988-12       Impact factor: 9.139

10.  Inhibition of methoxamine-induced bronchoconstriction by ipratropium bromide and disodium cromoglycate in asthmatic subjects.

Authors:  J Black; K Vincenc; C Salome
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.